Search by Drug Name or NDC
NDC 00178-0314-30 POTASSIUM IODIDE 65 mg/mL Details
POTASSIUM IODIDE 65 mg/mL
POTASSIUM IODIDE is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Mission Pharmacal Company. The primary component is POTASSIUM IODIDE.
MedlinePlus Drug Summary
Potassium iodide is used to protect the thyroid gland from taking in radioactive iodine that may be released during a nuclear radiation emergency. Radioactive iodine can damage the thyroid gland. You should only take potassium iodide if there is a nuclear radiation emergency and public officials tell you that you should take it. Potassium iodide is in a class of medications called anti-thyroid medications. It works by blocking radioactive iodine from entering the thyroid gland. Potassium iodide can protect you from the effects of radioactive iodine that may be released during a nuclear radiation emergency, but will not protect you from other dangerous substances that may be released during the emergency. Public officials may tell you to do other things to protect yourself during the emergency. Follow all of these directions carefully.
Related Packages: 00178-0314-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Potassium Iodide
Product Information
| NDC | 00178-0314 |
|---|---|
| Product ID | 0178-0314_f1e9c718-f2ec-1124-e053-2995a90a06ea |
| Associated GPIs | 93000065102020 |
| GCN Sequence Number | 036443 |
| GCN Sequence Number Description | potassium iodide DROPS 65 MG/ML ORAL |
| HIC3 | C3H |
| HIC3 Description | IODINE CONTAINING AGENTS |
| GCN | 95857 |
| HICL Sequence Number | 000748 |
| HICL Sequence Number Description | POTASSIUM IODIDE |
| Brand/Generic | Generic |
| Proprietary Name | POTASSIUM IODIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | POTASSIUM IODIDE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 65 |
| Active Ingredient Units | mg/mL |
| Substance Name | POTASSIUM IODIDE |
| Labeler Name | Mission Pharmacal Company |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206211 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00178-0314-30 (00178031430)
| NDC Package Code | 0178-0314-30 |
|---|---|
| Billing NDC | 00178031430 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (0178-0314-30) / 30 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2016-05-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |